76 studies found for:    Open Studies | "Skin Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Tumor Infiltrating Lymphocytes;   Drug: IL-15
22 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
23 Recruiting Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck
Condition: Skin Cancer
Interventions: Drug: Carboplatin;   Radiation: Radiotherapy
24 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
25 Recruiting Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck
Condition: Skin Cancer of the Head and Neck
Intervention:
26 Unknown  Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
Condition: Scar
Interventions: Drug: Dysport (abobotulinumtoxinA);   Drug: Bacteriostatic 0.9% Sodium Chloride (vehicle)
27 Recruiting Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
Conditions: Melanoma;   Skin Cancer
Interventions: Drug: Panobinostat;   Drug: Ipilimumab
28 Recruiting In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Condition: Skin Cancer
Intervention:
29 Not yet recruiting A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Conditions: Bladder Cancer;   Skin Cancers;   Bladder (Urothelial, Transitional Cell) Cancer;   Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
Intervention:
30 Recruiting Study of Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) of the Skin
Condition: Skin Cancer
Intervention: Drug: Erlotinib
31 Unknown  Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors
Conditions: Cancer of Skin;   Solid Tumors
Intervention: Procedure: Immunotherapy treatment for solid tumors
32 Recruiting Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
Conditions: Recurrent Skin Cancer;   Squamous Cell Carcinoma of the Skin
Interventions: Drug: capecitabine;   Other: laboratory biomarker analysis
33 Recruiting Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
Conditions: Melanoma;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma of the Skin;   Sarcoma of the Skin;   Basal Cell Cancer of the Skin;   Breast Cancer
Intervention: Drug: Poly-ICLC
34 Recruiting Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
Conditions: Actinic Keratosis;   Squamous Cell Carcinoma
Intervention: Procedure: Superficial shave biopsy
35 Recruiting Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Condition: Metastatic or Unresectable Cutaneous Melanoma
Interventions: Drug: MEK162;   Drug: Dacarbazine
36 Recruiting Calcium Electroporation for the Treatment of Cutaneous Metastases
Condition: Cutaneous Metastases
Interventions: Drug: Calcium electroporation;   Drug: Electrochemotherapy with bleomycin
37 Recruiting Minimal SN Tumor Burden
Condition: Cutaneous Melanoma
Intervention:
38 Recruiting Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma
Condition: Squamous Cell Skin Carcinoma
Intervention: Drug: Sirolimus
39 Recruiting A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Condition: Cutaneous Melanoma
Intervention:
40 Recruiting Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage II Verrucous Carcinoma of the Oral Cavity
Interventions: Drug: erlotinib hydrochloride;   Procedure: therapeutic conventional surgery

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years